| Name | Title | Contact Details |
|---|---|---|
Anjali Camara |
Managing Partner, Head of Cyber and Tech | Profile |
The San Francisco Giants are a professional Major League Baseball team in the National League West Division. Founded in 1883 as the New York Gothams, the team became the New York Giants in 1885 and moved to San Francisco in 1958. They play at Oracle Park, known for its stunning waterfront views and unique architecture. The Giants have a rich history, boasting 8 World Series titles, 23 National League pennants, and 9 division titles. The team is owned by Charles B. Johnson and Greg E. Johnson, with Larry Baer as president and Bob Melvin as manager. The organization focuses on providing entertainment through baseball games, merchandise sales, and community programs. They offer various experiences at Oracle Park, including tours and luxury suites, and engage with local fans through youth initiatives and educational outreach. The Giants also produce media content, including broadcasts and archival footage.
Tech Observer is a global Contract Research Organization (CRO) founded in 2005, with its headquarters in Paramus, New Jersey, and additional offices in New Delhi, Mumbai, and Singapore. The company specializes in clinical development support for the pharmaceutical, biotechnology, and medical device industries, extending its reach through local partners across the Asia-Pacific region. The company offers a comprehensive range of services that encompass the entire clinical research process. These include managing clinical trials, clinical data management, biostatistics and SAS programming, medical writing, post-marketing clinical studies, and staffing services. Tech Observer is ISO 9001:2008 and ISO 14155:2011 certified, demonstrating its commitment to quality and regulatory compliance. With a workforce of around 400 professionals, the company serves over 50 clients in more than 30 countries, focusing on various therapeutic areas such as oncology, cardiology, and infectious diseases. Tech Observer also emphasizes innovation with solutions like its AI-driven clinical trial risk tool, MyRBQM, and promotes diversity and professional growth within its team.